Nightmares and Memantine: A Case Report and Review of Literature

Journal of the American Medical Directors Association

Volumn 10, Issue 1, 2009, Pages 77-78

  Iraqi, Abid ^a   Hughes, Terry Lynn ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; DONEPEZIL; LISINOPRIL; MEMANTINE; SIMVASTATIN;

AGED; AMNESIA; CASE REPORT; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DAILY LIFE ACTIVITY; DISEASE DURATION; DRUG DOSE; DRUG REEXPOSURE; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MORNING DOSAGE; MULTIINFARCT DEMENTIA; NIGHTMARE; RECURRENT DISEASE; SCORING SYSTEM; SHORT TERM MEMORY; TREATMENT DURATION;

EID: 57849132174     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2008.10.001     Document Type: Letter

References (3)

1. Memantine [physician information insert] (2005), Forest Pharmaceuticals, Inc, St. Louis, MO
2. Rogawski M.A., and Wenk G.I. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug 9 (2003) 275-308
3. Huey E.D., Dustin I.H., Overman G.P., et al. Development of subtle psychotic symptoms with memantine: A case report. J Clin Psychiatry 66 (2005) 658-659